Prof. Vassilios Myrianthopoulos studied pharmacy at NKUA, Greece. He received his PhD in 2010 from the same institute, working on the rational design of small-molecule inhibitors of disease-relevant kinases with emphasis on molecules related to natural products. A part of his thesis was completed at the Structural Genomics Consortium, University of Oxford, with the group of Professor Stefan Knapp. Among other accomplishments, he has contributed to the development of two chemical probes, 6BIO and (R)-CR8, selectively targeting kinases GSK3β and CK1, respectively. From 2010 to 2018, he worked as a postdoctoral research fellow and a teaching associate in the Pharmaceutical Chemistry laboratory, University of Athens. In 2019, he was appointed as an Assistant Professor in the Pharmacy department of NKUA. His current research interests are focused on the combination of theoretical calculations and biophysical methodologies such as X-ray crystallography and fluorimetry for efficient hit identification and lead optimization, with special emphasis on the thermodynamic role of solvents in drug-target interaction events.